Modern Diagnostic & Research Centre reported a 6.8% rise in operating income to ₹8,311.06 lakh for FY26, while profit after tax (PAT) declined 41.7% to ₹525.33 lakh. The company has scheduled its 14th Annual General Meeting (AGM) for September 30, 2026, to adopt these audited financial statements.

The Board of Directors approved the AGM notice on September 3, 2026. The meeting will be held at Jaypee Siddharth 3 in New Delhi. Key agenda items include the re-appointment of director Smt. Deepali Yadav and statutory auditor M/s. Gupta Aiyer & Co. The board also considered governance matters under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Modern Diagnostic’s total income stood at ₹8,413.71 lakh, up from ₹7,880.46 lakh in FY25. Total expenses increased to ₹7,814.58 lakh from ₹6,593.49 lakh in the previous year. EBITDA margin contracted to 16.18% from 24.00% in FY25.

Book Closure and E-Voting Details

Pursuant to Regulation 42 of the Listing Regulations, the register of members and share transfer books will remain closed from September 23, 2026, to September 30, 2026. The record date for determining voting eligibility is September 23, 2026.

Shareholders can exercise their right to vote electronically via MUFG Intime India Private Limited. The e-voting period begins on September 27, 2026, at 9:00 am and ends on September 29, 2026, at 5:00 pm.

Corporate Governance Approvals

The board took note of the certificate of compliance of Integrated Corporate Governance for the quarter ended June 30, 2026. It approved the Director Responsibility Statement and the Secretarial Audit Report for the financial year ended March 31, 2026.

Director and Auditor Re-appointments

Smt. Deepali Yadav (DIN-06496670), who retires by rotation, was re-appointed as a director. The board also approved the re-appointment of CA Shammi Bansal, a partner at Gupta Aiyer & Co., as the Statutory Auditor for a term of five years until the conclusion of the AGM in 2031.

Operational Updates and Expansion

The board approved the Annual Report on CSR activities for FY26 and sanctioned the budget for CSR expenditures for FY27. In an operational update, the board terminated a business agreement with an associate managing the laboratory at Jaipur.

The company expanded its network by launching five new laboratories in Gurugram, East Delhi, Meerut, and Mohali. Infrastructure work for centres in Aligarh and Lucknow is nearly complete. Modern Diagnostic also introduced specialized diagnostic offerings, including LC-MS/MS-based Therapeutic Drug Monitoring panels.

Scrutinizer Profile

M/s. Kuldeep Bisht & Associates has been appointed as the scrutinizer for the 14th AGM. The firm will monitor the e-voting process to ensure regulatory compliance and transparency. Mr. Kuldeep Singh Bisht, an Associate Member of the Institute of Company Secretaries of India, brings over six years of experience in corporate secretarial matters.

Modern Diagnostic & Research Centre Limited has scheduled a board meeting for Thursday, September 3, 2026. The session will focus on administrative approvals, including the Annual General Meeting (AGM) notice.

The company issued the intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Priyanshu Yadav, Company Secretary & Compliance Officer, signed the disclosure dated August 26, 2026.

Agenda Items

The board will consider the following key matters:

• Appointment of Scrutinizer
• Approval of Director Report
• Approval of AGM notice
• Other businesses

This meeting is part of the standard pre-AGM procedural requirements for listed entities.